Key Insights
The global robotic neurorehabilitation market, valued at $0.84 billion in 2025, is poised for significant growth, exhibiting a Compound Annual Growth Rate (CAGR) of 19.76% from 2025 to 2033. This robust expansion is driven by several key factors. The increasing prevalence of neurological disorders like stroke, spinal cord injuries, and cerebral palsy fuels the demand for effective rehabilitation therapies. Robotic systems offer advantages over traditional methods, providing precise, repetitive movements and personalized training programs, leading to improved patient outcomes and reduced recovery times. Technological advancements, including the development of more sophisticated sensors, AI-powered algorithms for personalized treatment, and user-friendly interfaces, are further accelerating market growth. Furthermore, rising healthcare expenditure and increasing awareness of the benefits of robotic-assisted therapy among healthcare professionals and patients contribute to the market's expansion. The market is segmented by device type (exoskeletons, robots for upper limb rehabilitation, etc.), application (stroke rehabilitation, spinal cord injury rehabilitation, etc.), and end-user (hospitals, rehabilitation centers, etc.). Leading companies like Ekso Bionics, Tyromotion GmbH, and Hocoma are driving innovation and market penetration through continuous product development and strategic partnerships.
While the market faces challenges such as high initial investment costs for robotic systems and a limited reimbursement coverage in some regions, these obstacles are expected to be mitigated by technological advancements that reduce costs, growing awareness of the technology's cost-effectiveness in long-term care, and increasing government support for advanced rehabilitation technologies. The market’s future trajectory indicates strong potential for growth across various regions, with North America and Europe expected to dominate due to their advanced healthcare infrastructure and higher adoption rates. However, emerging economies in Asia-Pacific and Latin America are also showing promising growth potential as healthcare infrastructure improves and affordability increases. The market will continue to evolve with further integration of artificial intelligence and virtual reality to personalize and enhance the effectiveness of robotic neurorehabilitation therapies.

Robotic Neurorehabilitation Market: A Comprehensive Market Report (2019-2033)
This comprehensive report provides an in-depth analysis of the global Robotic Neurorehabilitation Market, offering invaluable insights for stakeholders, investors, and industry professionals. Covering the period from 2019 to 2033, with a focus on 2025 as the base and estimated year, this report projects significant growth opportunities within the sector. The study meticulously examines market segmentation, competitive dynamics, technological advancements, and key growth drivers, equipping readers with actionable intelligence to navigate this evolving landscape.
Robotic Neurorehabilitation Market Structure & Competitive Dynamics
The Robotic Neurorehabilitation Market exhibits a moderately concentrated structure, with several key players holding significant market share. However, the market is also characterized by a dynamic competitive landscape, fuelled by ongoing innovation and strategic mergers and acquisitions (M&A). The market share distribution amongst the top 10 players in 2025 is estimated at 60%, indicating a considerable level of concentration. Smaller companies focusing on niche applications and technological innovations also contribute to the market's vibrancy.
The regulatory framework governing medical devices, including robotic neurorehabilitation systems, varies across different geographies. Stringent regulatory approvals and compliance requirements present both challenges and opportunities. The market sees substantial innovation driven by the continuous development of advanced robotics, sensors, and AI-powered rehabilitation platforms. Substitution effects are limited, with robotic systems offering unique advantages over traditional therapies. End-user trends highlight a growing preference for personalized and effective rehabilitation solutions, driving the demand for sophisticated robotic systems. M&A activity has been significant, with deal values in the past five years exceeding xx Million. Notable examples include the business combination of DIH (Hocoma) and Aurora Technology Acquisition Corporation in February 2024. Such activity demonstrates the strategic importance of consolidation within the industry to expand market reach and technological capabilities.
- Market Concentration: Estimated at 60% for top 10 players in 2025.
- M&A Activity: Deal values exceeding xx Million in the past 5 years.
- Regulatory Landscape: Varies by geography; stringent approvals needed.
- Innovation Ecosystem: Strong focus on advanced robotics, AI, and sensor integration.
- Product Substitutes: Limited; robotic systems offer unique benefits.
- End-User Trends: Growing demand for personalized and effective therapies.
Robotic Neurorehabilitation Market Industry Trends & Insights
The global Robotic Neurorehabilitation Market is poised for robust growth, projected to achieve a Compound Annual Growth Rate (CAGR) of xx% during the forecast period (2025-2033). This expansion is driven by several key factors. The aging global population and the rising prevalence of neurological disorders, including stroke, Parkinson's disease, and spinal cord injuries, are significantly boosting market demand. Technological advancements, such as the integration of artificial intelligence (AI) and virtual reality (VR) into robotic systems, are enhancing treatment efficacy and patient engagement. Increasing healthcare expenditure and the growing adoption of advanced medical technologies further contribute to market growth. Consumer preferences are shifting towards personalized, data-driven rehabilitation approaches, aligning perfectly with the capabilities of robotic systems. Competitive dynamics are characterized by continuous innovation, strategic partnerships, and market consolidation, leading to a more refined and efficient market offering. Market penetration, currently at xx%, is expected to increase substantially over the forecast period, driven by factors mentioned above and increased awareness of the benefits of robotic neurorehabilitation.

Dominant Markets & Segments in Robotic Neurorehabilitation Market
North America currently dominates the Robotic Neurorehabilitation Market, driven by factors including advanced healthcare infrastructure, high healthcare expenditure, and a large patient pool. The region's strong regulatory framework and the presence of major market players also contribute to its dominance.
- Key Drivers in North America:
- Advanced healthcare infrastructure.
- High healthcare expenditure.
- Large patient pool with neurological disorders.
- Favorable regulatory environment.
- Presence of major market players.
Europe also holds a significant market share, with countries like Germany and France showing strong growth due to increasing government support for healthcare innovation and a focus on improving rehabilitation outcomes. Asia-Pacific is projected to experience substantial growth in the coming years, fueled by rapidly rising healthcare spending and an increasing prevalence of neurological disorders in developing economies.
Robotic Neurorehabilitation Market Product Innovations
Recent product developments have focused on enhancing the functionalities of robotic neurorehabilitation systems, such as integrating advanced sensors for precise movement tracking, incorporating AI for personalized treatment plans, and utilizing virtual reality for immersive and engaging rehabilitation exercises. These innovations aim to improve treatment outcomes, enhance patient compliance, and reduce the overall cost of care. The market is witnessing a shift towards more compact and user-friendly designs, making robotic systems more accessible for home-based rehabilitation. The competitive advantage increasingly lies in the ability to offer personalized and data-driven solutions that cater to the specific needs of individual patients.
Report Segmentation & Scope
This report segments the Robotic Neurorehabilitation Market based on several key parameters:
- By Product Type: Exoskeletons, robotic-assisted devices, virtual reality-based systems, and others. The exoskeleton segment is projected to hold the largest market share due to its efficacy in treating various neurological conditions.
- By Application: Stroke rehabilitation, spinal cord injury rehabilitation, Parkinson's disease rehabilitation, and others. Stroke rehabilitation represents the largest application segment, driven by its high prevalence.
- By End-User: Hospitals & rehabilitation centers, home care settings, and others. Hospitals and rehabilitation centers currently dominate the market, but home care is showing significant growth.
Each segment's growth projections, market sizes, and competitive dynamics are detailed in the full report.
Key Drivers of Robotic Neurorehabilitation Market Growth
Several factors are driving the growth of the Robotic Neurorehabilitation Market. Technological advancements, such as AI-powered systems and VR integration, are improving treatment efficacy. Rising prevalence of neurological disorders is increasing demand for effective rehabilitation solutions. Government initiatives and funding programs aimed at promoting healthcare innovation are boosting market growth. Increasing healthcare expenditure and the rising adoption of advanced medical technologies are also major contributors.
Challenges in the Robotic Neurorehabilitation Market Sector
Despite significant growth potential, the Robotic Neurorehabilitation Market faces several challenges. High initial investment costs for robotic systems can be a barrier to adoption. Stringent regulatory approvals and compliance requirements can delay product launches. The complexity of integrating robotic systems into existing healthcare workflows can hinder widespread adoption. Competition among established players and new entrants is intensifying, creating pressure on pricing and margins. The lack of skilled professionals proficient in operating and maintaining robotic systems poses a significant challenge.
Leading Players in the Robotic Neurorehabilitation Market Market
- Humanware S r l
- Tyromotion GmbH
- DIH (Hocoma)
- BIONIK
- Lifeward Inc
- MagVenture Inc
- Ekso Bionics
- Rehab-Robotics Company Limited
- eodyne
- Neofect
- Reha Technology AG
- Barrett
*List Not Exhaustive
Key Developments in Robotic Neurorehabilitation Market Sector
- February 2024: DIH (Hocoma) completed its business combination with Aurora Technology Acquisition Corporation, expanding its market reach and strengthening its position in robotic and VR-enabled rehabilitation.
- January 2024: ReWalk Robotics Ltd rebranded as Lifeward Inc., focusing on delivering physical and neurological rehabilitation solutions.
Strategic Robotic Neurorehabilitation Market Outlook
The Robotic Neurorehabilitation Market presents a substantial opportunity for growth in the coming years. Continued technological advancements, coupled with the increasing prevalence of neurological disorders and rising healthcare expenditure, will fuel market expansion. Strategic partnerships between technology providers and healthcare institutions will be crucial for successful market penetration. Companies focusing on personalized and data-driven solutions, coupled with strong regulatory compliance, are expected to gain a competitive edge. The market's future hinges on delivering cost-effective, accessible, and highly effective rehabilitation solutions.
Robotic Neurorehabilitation Market Segmentation
-
1. Product Type
-
1.1. Devices
- 1.1.1. Upper Extremity
- 1.1.2. Lower Extremity
- 1.2. Consumable and Accessories
- 1.3. Software and Services
-
1.1. Devices
-
2. End User
- 2.1. Hospitals/Clinics
- 2.2. Cognitive Care Centers
- 2.3. Other End Users
Robotic Neurorehabilitation Market Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. Europe
- 2.1. Germany
- 2.2. United Kingdom
- 2.3. France
- 2.4. Italy
- 2.5. Spain
- 2.6. Rest of Europe
-
3. Asia Pacific
- 3.1. China
- 3.2. Japan
- 3.3. India
- 3.4. Australia
- 3.5. South Korea
- 3.6. Rest of Asia Pacific
- 4. Rest of the World

Robotic Neurorehabilitation Market REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 19.76% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Prevalence of Neurological Disorders; Clinical Outcomes Offered Over Conventional Methods; Technological Advancements in Robotic Devices
- 3.3. Market Restrains
- 3.3.1. Increasing Prevalence of Neurological Disorders; Clinical Outcomes Offered Over Conventional Methods; Technological Advancements in Robotic Devices
- 3.4. Market Trends
- 3.4.1. Devices Segment is Expected to Witness Growth Over the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Robotic Neurorehabilitation Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Product Type
- 5.1.1. Devices
- 5.1.1.1. Upper Extremity
- 5.1.1.2. Lower Extremity
- 5.1.2. Consumable and Accessories
- 5.1.3. Software and Services
- 5.1.1. Devices
- 5.2. Market Analysis, Insights and Forecast - by End User
- 5.2.1. Hospitals/Clinics
- 5.2.2. Cognitive Care Centers
- 5.2.3. Other End Users
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. Asia Pacific
- 5.3.4. Rest of the World
- 5.1. Market Analysis, Insights and Forecast - by Product Type
- 6. North America Robotic Neurorehabilitation Market Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Product Type
- 6.1.1. Devices
- 6.1.1.1. Upper Extremity
- 6.1.1.2. Lower Extremity
- 6.1.2. Consumable and Accessories
- 6.1.3. Software and Services
- 6.1.1. Devices
- 6.2. Market Analysis, Insights and Forecast - by End User
- 6.2.1. Hospitals/Clinics
- 6.2.2. Cognitive Care Centers
- 6.2.3. Other End Users
- 6.1. Market Analysis, Insights and Forecast - by Product Type
- 7. Europe Robotic Neurorehabilitation Market Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Product Type
- 7.1.1. Devices
- 7.1.1.1. Upper Extremity
- 7.1.1.2. Lower Extremity
- 7.1.2. Consumable and Accessories
- 7.1.3. Software and Services
- 7.1.1. Devices
- 7.2. Market Analysis, Insights and Forecast - by End User
- 7.2.1. Hospitals/Clinics
- 7.2.2. Cognitive Care Centers
- 7.2.3. Other End Users
- 7.1. Market Analysis, Insights and Forecast - by Product Type
- 8. Asia Pacific Robotic Neurorehabilitation Market Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Product Type
- 8.1.1. Devices
- 8.1.1.1. Upper Extremity
- 8.1.1.2. Lower Extremity
- 8.1.2. Consumable and Accessories
- 8.1.3. Software and Services
- 8.1.1. Devices
- 8.2. Market Analysis, Insights and Forecast - by End User
- 8.2.1. Hospitals/Clinics
- 8.2.2. Cognitive Care Centers
- 8.2.3. Other End Users
- 8.1. Market Analysis, Insights and Forecast - by Product Type
- 9. Rest of the World Robotic Neurorehabilitation Market Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - by Product Type
- 9.1.1. Devices
- 9.1.1.1. Upper Extremity
- 9.1.1.2. Lower Extremity
- 9.1.2. Consumable and Accessories
- 9.1.3. Software and Services
- 9.1.1. Devices
- 9.2. Market Analysis, Insights and Forecast - by End User
- 9.2.1. Hospitals/Clinics
- 9.2.2. Cognitive Care Centers
- 9.2.3. Other End Users
- 9.1. Market Analysis, Insights and Forecast - by Product Type
- 10. Competitive Analysis
- 10.1. Global Market Share Analysis 2024
- 10.2. Company Profiles
- 10.2.1 Humanware S r l
- 10.2.1.1. Overview
- 10.2.1.2. Products
- 10.2.1.3. SWOT Analysis
- 10.2.1.4. Recent Developments
- 10.2.1.5. Financials (Based on Availability)
- 10.2.2 Tyromotion GmbH
- 10.2.2.1. Overview
- 10.2.2.2. Products
- 10.2.2.3. SWOT Analysis
- 10.2.2.4. Recent Developments
- 10.2.2.5. Financials (Based on Availability)
- 10.2.3 DIH (Hocoma)
- 10.2.3.1. Overview
- 10.2.3.2. Products
- 10.2.3.3. SWOT Analysis
- 10.2.3.4. Recent Developments
- 10.2.3.5. Financials (Based on Availability)
- 10.2.4 BIONIK
- 10.2.4.1. Overview
- 10.2.4.2. Products
- 10.2.4.3. SWOT Analysis
- 10.2.4.4. Recent Developments
- 10.2.4.5. Financials (Based on Availability)
- 10.2.5 Lifeward Inc
- 10.2.5.1. Overview
- 10.2.5.2. Products
- 10.2.5.3. SWOT Analysis
- 10.2.5.4. Recent Developments
- 10.2.5.5. Financials (Based on Availability)
- 10.2.6 MagVenture Inc
- 10.2.6.1. Overview
- 10.2.6.2. Products
- 10.2.6.3. SWOT Analysis
- 10.2.6.4. Recent Developments
- 10.2.6.5. Financials (Based on Availability)
- 10.2.7 Ekso Bionics
- 10.2.7.1. Overview
- 10.2.7.2. Products
- 10.2.7.3. SWOT Analysis
- 10.2.7.4. Recent Developments
- 10.2.7.5. Financials (Based on Availability)
- 10.2.8 Rehab-Robotics Company Limited
- 10.2.8.1. Overview
- 10.2.8.2. Products
- 10.2.8.3. SWOT Analysis
- 10.2.8.4. Recent Developments
- 10.2.8.5. Financials (Based on Availability)
- 10.2.9 eodyne
- 10.2.9.1. Overview
- 10.2.9.2. Products
- 10.2.9.3. SWOT Analysis
- 10.2.9.4. Recent Developments
- 10.2.9.5. Financials (Based on Availability)
- 10.2.10 Neofect
- 10.2.10.1. Overview
- 10.2.10.2. Products
- 10.2.10.3. SWOT Analysis
- 10.2.10.4. Recent Developments
- 10.2.10.5. Financials (Based on Availability)
- 10.2.11 Reha Technology AG
- 10.2.11.1. Overview
- 10.2.11.2. Products
- 10.2.11.3. SWOT Analysis
- 10.2.11.4. Recent Developments
- 10.2.11.5. Financials (Based on Availability)
- 10.2.12 Barrett*List Not Exhaustive
- 10.2.12.1. Overview
- 10.2.12.2. Products
- 10.2.12.3. SWOT Analysis
- 10.2.12.4. Recent Developments
- 10.2.12.5. Financials (Based on Availability)
- 10.2.1 Humanware S r l
List of Figures
- Figure 1: Global Robotic Neurorehabilitation Market Revenue Breakdown (Million, %) by Region 2024 & 2032
- Figure 2: Global Robotic Neurorehabilitation Market Volume Breakdown (Billion, %) by Region 2024 & 2032
- Figure 3: North America Robotic Neurorehabilitation Market Revenue (Million), by Product Type 2024 & 2032
- Figure 4: North America Robotic Neurorehabilitation Market Volume (Billion), by Product Type 2024 & 2032
- Figure 5: North America Robotic Neurorehabilitation Market Revenue Share (%), by Product Type 2024 & 2032
- Figure 6: North America Robotic Neurorehabilitation Market Volume Share (%), by Product Type 2024 & 2032
- Figure 7: North America Robotic Neurorehabilitation Market Revenue (Million), by End User 2024 & 2032
- Figure 8: North America Robotic Neurorehabilitation Market Volume (Billion), by End User 2024 & 2032
- Figure 9: North America Robotic Neurorehabilitation Market Revenue Share (%), by End User 2024 & 2032
- Figure 10: North America Robotic Neurorehabilitation Market Volume Share (%), by End User 2024 & 2032
- Figure 11: North America Robotic Neurorehabilitation Market Revenue (Million), by Country 2024 & 2032
- Figure 12: North America Robotic Neurorehabilitation Market Volume (Billion), by Country 2024 & 2032
- Figure 13: North America Robotic Neurorehabilitation Market Revenue Share (%), by Country 2024 & 2032
- Figure 14: North America Robotic Neurorehabilitation Market Volume Share (%), by Country 2024 & 2032
- Figure 15: Europe Robotic Neurorehabilitation Market Revenue (Million), by Product Type 2024 & 2032
- Figure 16: Europe Robotic Neurorehabilitation Market Volume (Billion), by Product Type 2024 & 2032
- Figure 17: Europe Robotic Neurorehabilitation Market Revenue Share (%), by Product Type 2024 & 2032
- Figure 18: Europe Robotic Neurorehabilitation Market Volume Share (%), by Product Type 2024 & 2032
- Figure 19: Europe Robotic Neurorehabilitation Market Revenue (Million), by End User 2024 & 2032
- Figure 20: Europe Robotic Neurorehabilitation Market Volume (Billion), by End User 2024 & 2032
- Figure 21: Europe Robotic Neurorehabilitation Market Revenue Share (%), by End User 2024 & 2032
- Figure 22: Europe Robotic Neurorehabilitation Market Volume Share (%), by End User 2024 & 2032
- Figure 23: Europe Robotic Neurorehabilitation Market Revenue (Million), by Country 2024 & 2032
- Figure 24: Europe Robotic Neurorehabilitation Market Volume (Billion), by Country 2024 & 2032
- Figure 25: Europe Robotic Neurorehabilitation Market Revenue Share (%), by Country 2024 & 2032
- Figure 26: Europe Robotic Neurorehabilitation Market Volume Share (%), by Country 2024 & 2032
- Figure 27: Asia Pacific Robotic Neurorehabilitation Market Revenue (Million), by Product Type 2024 & 2032
- Figure 28: Asia Pacific Robotic Neurorehabilitation Market Volume (Billion), by Product Type 2024 & 2032
- Figure 29: Asia Pacific Robotic Neurorehabilitation Market Revenue Share (%), by Product Type 2024 & 2032
- Figure 30: Asia Pacific Robotic Neurorehabilitation Market Volume Share (%), by Product Type 2024 & 2032
- Figure 31: Asia Pacific Robotic Neurorehabilitation Market Revenue (Million), by End User 2024 & 2032
- Figure 32: Asia Pacific Robotic Neurorehabilitation Market Volume (Billion), by End User 2024 & 2032
- Figure 33: Asia Pacific Robotic Neurorehabilitation Market Revenue Share (%), by End User 2024 & 2032
- Figure 34: Asia Pacific Robotic Neurorehabilitation Market Volume Share (%), by End User 2024 & 2032
- Figure 35: Asia Pacific Robotic Neurorehabilitation Market Revenue (Million), by Country 2024 & 2032
- Figure 36: Asia Pacific Robotic Neurorehabilitation Market Volume (Billion), by Country 2024 & 2032
- Figure 37: Asia Pacific Robotic Neurorehabilitation Market Revenue Share (%), by Country 2024 & 2032
- Figure 38: Asia Pacific Robotic Neurorehabilitation Market Volume Share (%), by Country 2024 & 2032
- Figure 39: Rest of the World Robotic Neurorehabilitation Market Revenue (Million), by Product Type 2024 & 2032
- Figure 40: Rest of the World Robotic Neurorehabilitation Market Volume (Billion), by Product Type 2024 & 2032
- Figure 41: Rest of the World Robotic Neurorehabilitation Market Revenue Share (%), by Product Type 2024 & 2032
- Figure 42: Rest of the World Robotic Neurorehabilitation Market Volume Share (%), by Product Type 2024 & 2032
- Figure 43: Rest of the World Robotic Neurorehabilitation Market Revenue (Million), by End User 2024 & 2032
- Figure 44: Rest of the World Robotic Neurorehabilitation Market Volume (Billion), by End User 2024 & 2032
- Figure 45: Rest of the World Robotic Neurorehabilitation Market Revenue Share (%), by End User 2024 & 2032
- Figure 46: Rest of the World Robotic Neurorehabilitation Market Volume Share (%), by End User 2024 & 2032
- Figure 47: Rest of the World Robotic Neurorehabilitation Market Revenue (Million), by Country 2024 & 2032
- Figure 48: Rest of the World Robotic Neurorehabilitation Market Volume (Billion), by Country 2024 & 2032
- Figure 49: Rest of the World Robotic Neurorehabilitation Market Revenue Share (%), by Country 2024 & 2032
- Figure 50: Rest of the World Robotic Neurorehabilitation Market Volume Share (%), by Country 2024 & 2032
List of Tables
- Table 1: Global Robotic Neurorehabilitation Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Global Robotic Neurorehabilitation Market Volume Billion Forecast, by Region 2019 & 2032
- Table 3: Global Robotic Neurorehabilitation Market Revenue Million Forecast, by Product Type 2019 & 2032
- Table 4: Global Robotic Neurorehabilitation Market Volume Billion Forecast, by Product Type 2019 & 2032
- Table 5: Global Robotic Neurorehabilitation Market Revenue Million Forecast, by End User 2019 & 2032
- Table 6: Global Robotic Neurorehabilitation Market Volume Billion Forecast, by End User 2019 & 2032
- Table 7: Global Robotic Neurorehabilitation Market Revenue Million Forecast, by Region 2019 & 2032
- Table 8: Global Robotic Neurorehabilitation Market Volume Billion Forecast, by Region 2019 & 2032
- Table 9: Global Robotic Neurorehabilitation Market Revenue Million Forecast, by Product Type 2019 & 2032
- Table 10: Global Robotic Neurorehabilitation Market Volume Billion Forecast, by Product Type 2019 & 2032
- Table 11: Global Robotic Neurorehabilitation Market Revenue Million Forecast, by End User 2019 & 2032
- Table 12: Global Robotic Neurorehabilitation Market Volume Billion Forecast, by End User 2019 & 2032
- Table 13: Global Robotic Neurorehabilitation Market Revenue Million Forecast, by Country 2019 & 2032
- Table 14: Global Robotic Neurorehabilitation Market Volume Billion Forecast, by Country 2019 & 2032
- Table 15: United States Robotic Neurorehabilitation Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 16: United States Robotic Neurorehabilitation Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 17: Canada Robotic Neurorehabilitation Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 18: Canada Robotic Neurorehabilitation Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 19: Mexico Robotic Neurorehabilitation Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 20: Mexico Robotic Neurorehabilitation Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 21: Global Robotic Neurorehabilitation Market Revenue Million Forecast, by Product Type 2019 & 2032
- Table 22: Global Robotic Neurorehabilitation Market Volume Billion Forecast, by Product Type 2019 & 2032
- Table 23: Global Robotic Neurorehabilitation Market Revenue Million Forecast, by End User 2019 & 2032
- Table 24: Global Robotic Neurorehabilitation Market Volume Billion Forecast, by End User 2019 & 2032
- Table 25: Global Robotic Neurorehabilitation Market Revenue Million Forecast, by Country 2019 & 2032
- Table 26: Global Robotic Neurorehabilitation Market Volume Billion Forecast, by Country 2019 & 2032
- Table 27: Germany Robotic Neurorehabilitation Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 28: Germany Robotic Neurorehabilitation Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 29: United Kingdom Robotic Neurorehabilitation Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 30: United Kingdom Robotic Neurorehabilitation Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 31: France Robotic Neurorehabilitation Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 32: France Robotic Neurorehabilitation Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 33: Italy Robotic Neurorehabilitation Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 34: Italy Robotic Neurorehabilitation Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 35: Spain Robotic Neurorehabilitation Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 36: Spain Robotic Neurorehabilitation Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 37: Rest of Europe Robotic Neurorehabilitation Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 38: Rest of Europe Robotic Neurorehabilitation Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 39: Global Robotic Neurorehabilitation Market Revenue Million Forecast, by Product Type 2019 & 2032
- Table 40: Global Robotic Neurorehabilitation Market Volume Billion Forecast, by Product Type 2019 & 2032
- Table 41: Global Robotic Neurorehabilitation Market Revenue Million Forecast, by End User 2019 & 2032
- Table 42: Global Robotic Neurorehabilitation Market Volume Billion Forecast, by End User 2019 & 2032
- Table 43: Global Robotic Neurorehabilitation Market Revenue Million Forecast, by Country 2019 & 2032
- Table 44: Global Robotic Neurorehabilitation Market Volume Billion Forecast, by Country 2019 & 2032
- Table 45: China Robotic Neurorehabilitation Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 46: China Robotic Neurorehabilitation Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 47: Japan Robotic Neurorehabilitation Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 48: Japan Robotic Neurorehabilitation Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 49: India Robotic Neurorehabilitation Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 50: India Robotic Neurorehabilitation Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 51: Australia Robotic Neurorehabilitation Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 52: Australia Robotic Neurorehabilitation Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 53: South Korea Robotic Neurorehabilitation Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 54: South Korea Robotic Neurorehabilitation Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 55: Rest of Asia Pacific Robotic Neurorehabilitation Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 56: Rest of Asia Pacific Robotic Neurorehabilitation Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 57: Global Robotic Neurorehabilitation Market Revenue Million Forecast, by Product Type 2019 & 2032
- Table 58: Global Robotic Neurorehabilitation Market Volume Billion Forecast, by Product Type 2019 & 2032
- Table 59: Global Robotic Neurorehabilitation Market Revenue Million Forecast, by End User 2019 & 2032
- Table 60: Global Robotic Neurorehabilitation Market Volume Billion Forecast, by End User 2019 & 2032
- Table 61: Global Robotic Neurorehabilitation Market Revenue Million Forecast, by Country 2019 & 2032
- Table 62: Global Robotic Neurorehabilitation Market Volume Billion Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Robotic Neurorehabilitation Market?
The projected CAGR is approximately 19.76%.
2. Which companies are prominent players in the Robotic Neurorehabilitation Market?
Key companies in the market include Humanware S r l, Tyromotion GmbH, DIH (Hocoma), BIONIK, Lifeward Inc, MagVenture Inc, Ekso Bionics, Rehab-Robotics Company Limited, eodyne, Neofect, Reha Technology AG, Barrett*List Not Exhaustive.
3. What are the main segments of the Robotic Neurorehabilitation Market?
The market segments include Product Type, End User.
4. Can you provide details about the market size?
The market size is estimated to be USD 0.84 Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Prevalence of Neurological Disorders; Clinical Outcomes Offered Over Conventional Methods; Technological Advancements in Robotic Devices.
6. What are the notable trends driving market growth?
Devices Segment is Expected to Witness Growth Over the Forecast Period.
7. Are there any restraints impacting market growth?
Increasing Prevalence of Neurological Disorders; Clinical Outcomes Offered Over Conventional Methods; Technological Advancements in Robotic Devices.
8. Can you provide examples of recent developments in the market?
In February 2024, DIH, a robotics and virtual reality provider in rehabilitation, completed its business combination with Aurora Technology Acquisition Corporation to grow a strategic market base and expand its position in robotic and virtual reality-enabled rehabilitation technology.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in Billion.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Robotic Neurorehabilitation Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Robotic Neurorehabilitation Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Robotic Neurorehabilitation Market?
To stay informed about further developments, trends, and reports in the Robotic Neurorehabilitation Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence